This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Iron status has been investigated in relation to female fertility through multiple lines of evidence. The most-cited finding is from the Nurses' Health Study II prospective cohort (Chavarro 2006; n=18,555 women): iron supplement users had RR 0.60 (95% CI 0.39-0.92) for ovulatory infertility versus non-users. This has not been consistently replicated. Hahn 2019 and Jiménez-Cardozo 2023 found no consistent association. The evidence supports investigating iron status in fertility workups but does not support a single consensus ferritin target.
Investigating both iron and thyroid status concurrently in fertility workups is supported by this combined evidence. The mechanistic chain (iron deficiency, thyroid peroxidase impairment, thyroid hormone synthesis reduction, fertility effect) is biologically plausible. Direct mechanistic evidence linking iron status to specific reproductive outcomes (ovulation, implantation, embryo development) outside of thyroid mediation is more limited.
Studies in transfusion-dependent beta-thalassemia major report lower ovarian volume, antral follicle count, and AMH levels relative to age-matched controls, interpreted as evidence of a gonadotoxic effect of iron overload (Singer 2011, Uysal 2017, Talaulikar 2019, summarised in Jiménez-Cardozo 2023). Iron overload is also associated with broader cardiometabolic risks. Self-supplementation with iron without confirmed deficiency can be harmful, particularly in haemochromatosis or other iron-loading conditions.
Co-existing iron deficiency and subclinical hypothyroidism in fertility contexts: no specific RCT; supported by mechanistic plausibility and Garofalo 2023 systematic review of iron-thyroid associations. A U-shaped association has been observed between haemoglobin and miscarriage incidence, with optimal range around 120-130 g/L and higher miscarriage incidence both below 110 g/L and above 140 g/L. This is consistent with the broader principle that both iron deficiency and iron excess can adversely affect reproductive outcomes.
Inflammation elevates hepcidin, suppressing iron absorption and elevating ferritin as an acute-phase reactant. CRP-paired ferritin interpretation is essential when investigating iron status in fertility workups, particularly where conditions associated with low-grade inflammation (endometriosis, PCOS, autoimmune thyroid disease) are present.
| Interaction | Issue | Guidance | Citation |
|---|---|---|---|
| Iron and calcium | Calcium reduces non-haem iron absorption | Separate iron supplements from calcium-containing meals by around 2 hours | NIH ODS — Iron Fact Sheet for Health Professionals |
| Iron and vitamin C | Vitamin C enhances non-haem iron absorption (single-meal effect; long-term clinical benefit less reliable) | Take iron with a vitamin C source such as orange juice | NIH ODS — Iron Fact Sheet for Health Professionals |
Chavarro 2006 reported 438 women with infertility due to ovulatory disorder during 8 years of follow-up; iron supplement users had RR 0.60 (95% CI 0.39-0.92) for ovulatory infertility versus non-users. The highest non-haem iron intake quintile (median 76 mg/day) showed 40% lower risk than the lowest quintile (median 9.7 mg/day). Haem iron intake was unrelated to ovulatory infertility. Tulenheimo-Silfvast 2025 (Acta Obstet Gynecol Scand) retrospective cohort observed conception in some subfertile women with iron deficiency repletion. The Garofalo 2023 systematic review (Nutrients 15(22):4790) anchors the iron-thyroid mediation pathway.
Ferritin is the standard screening biomarker; interpret alongside CRP if inflammation is possible. Haemoglobin and MCV can remain within normal range despite iron deficiency, so isolated reliance on a complete blood count is not sufficient. The clinical message: investigate iron status in fertility workups, but do not assume routine high-dose iron supplementation is beneficial in iron-replete women. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.
Claim: more iron is always better for fertility. Iron overload is documented to have gonadotoxic effects in transfusion-dependent thalassemia (Singer 2011, Uysal 2017, Talaulikar 2019). The Chavarro 2006 finding of 40% reduced ovulatory infertility risk in highest non-haem iron intake quintile has not been consistently replicated; Hahn 2019 and Jiménez-Cardozo 2023 found no association. The honest framing is investigate iron status, address deficiency where present, do not assume routine high-dose supplementation in iron-replete women is beneficial.
This entry is relevant for the following groups, conditions, and medication contexts: